The Autonomous Clinic: Navigating AI, Sensors and the Equity Gap in Modern Physiotherapy

Digital Physiotherapy and the Equity Question: A Critical Narrative Review of Ethical, Access and Workforce Implications of Technology-Enabled Rehabilitation

2026-09-14T08:05:45+00:00

Technology-enabled rehabilitation has moved from the margins of physiotherapy practice to a routine service option within a single decade, propelled by pandemic-era necessity, favourable trial results and sustained policy enthusiasm for digital health. The dominant justification offered for this shift is that remote and digitally mediated care widens access for people who cannot easily reach a clinic. This critical narrative review interrogates that justification. It synthesises evidence on effectiveness, access, ethics and workforce consequences of digital physiotherapy, and evaluates whether the equity claim is supported by the available literature. Sources were identified through structured searching of biomedical and multidisciplinary scholarly databases and authoritative institutional repositories, with critical appraisal of methodological quality, evidence–claim alignment and geographical representativeness. The synthesis identifies a persistent mismatch between an efficacy literature drawn largely from connected, literate, high-income and predominantly urban samples and an equity rhetoric that invokes rural, disabled, older and low-income populations who are systematically under-represented in that same literature. Comparable clinical outcomes between remote and in-person physiotherapy are reasonably well supported for musculoskeletal and selected neurological conditions, yet this finding speaks to efficacy among those who enrol rather than to distributional effect across a population. Ethical analysis of digital physiotherapy remains thin and inconsistently reported, particularly regarding consent to commercial data processing, adverse-event surveillance, the altered therapeutic relationship and the governance of algorithmic tools. Workforce evidence indicates that digital health competencies are largely absent from physiotherapy competency standards and that clinician capability lags behind organisational deployment. Three arguments are advanced: that access should be conceptualised as realised benefit rather than nominal availability; that digital substitution risks displacing rather than supplementing scarce services in low-resource settings; and that equity outcomes must be measured as trial endpoints rather than assumed. Research priorities are proposed accordingly.

Brain–Computer Interfaces and Robotic Exoskeletons in Severe Post-Stroke Motor Impairment: A Critical Narrative Review of a Convergent Rehabilitation Framework

2026-09-14T08:09:58+00:00

Severe motor impairment is the clinical situation in which post-stroke rehabilitation performs least well, because most active therapies presuppose a degree of residual voluntary movement that the most affected survivors do not possess. Two technologies have been proposed to close this gap. Brain–computer interfaces (BCIs) detect movement-related cortical activity, most often modulation of sensorimotor rhythms recorded by electroencephalography (EEG), and therefore provide an output channel that does not depend on residual muscle activation. Robotic exoskeletons apply torque across anatomically aligned joints and can deliver structured, repeatable and proprioceptively rich movement to a limb that cannot move itself. Coupling the two creates a closed loop in which decoded intention is rewarded immediately with a somatosensory consequence. This review asks whether that convergence constitutes a coherent therapeutic framework for severe stroke, or an assembly of components whose separate limitations persist when they are combined. Literature was identified through structured searching of major open scholarly sources up to 17 June 2026, supplemented by backward and forward citation tracking and by appraisal of methodological quality. The available evidence indicates that contingent closed-loop training alters cortical and corticospinal measures in ways that non-contingent conditions do not, and that trials coupling interface control to peripheral actuation generally report favourable impairment-level effects. Confidence in the magnitude and durability of those effects is limited by small samples, inconsistent comparator design, incomplete dose matching, and outcome batteries that capture impairment more reliably than everyday limb use. Evidence specific to severe impairment is thinner still, because the participants with the greatest deficit are the participants most often excluded at screening, most likely to yield unstable decoding, and least well served by activity-level instruments. Exoskeleton-specific evidence is not interchangeable with evidence from end-effector robots or electrical stimulation, although reviews frequently pool them. Priorities include severity-stratified trials with contingency-controlled comparators, decoding strategies validated in lesioned brains, outcome measures sensitive at the floor, and economic evaluation conducted at service scale.

Telerehabilitation in Physiotherapy After COVID-19: A Critical Narrative Review of Effectiveness, Equity and the Adoption Paradox

2026-09-14T08:13:43+00:00

Background: The coronavirus disease 2019 pandemic converted telerehabilitation in physiotherapy from a marginal service model into a mainstream one within weeks, and generated an unusually rapid accumulation of trial evidence, professional guidance and health-system experience.

Purpose and Scope: This critical narrative review examines three interlocking questions that the post-pandemic literature has largely addressed in isolation: how strong the effectiveness evidence for physiotherapy telerehabilitation actually is, whether the model narrows or widens inequities in access to rehabilitation, and why utilisation contracted in many settings once emergency conditions ended despite favourable evidence.

Approach: Peer-reviewed literature was identified through structured searching of biomedical and multidisciplinary scholarly indexes, supplemented by citation tracking and authoritative institutional sources, with priority given to randomised trials, quantitative syntheses, implementation studies and equity-focused analyses.

Principal Findings: Equivalence with in-person care is reasonably well supported for supervised exercise-based interventions in musculoskeletal, cardiac and chronic respiratory populations, and adherence and satisfaction are generally comparable or better. Confidence weakens considerably where interventions depend on manual assessment or handling, where comparators are inactive, and where effect estimates are pooled across heterogeneous delivery architectures. Equity claims rest on an unresolved inversion: the populations with the greatest unmet rehabilitation need frequently have the weakest connectivity, device access and digital confidence, and they are systematically under-represented in the trials that underpin equivalence claims. The contraction of utilisation after the emergency phase is better explained by reimbursement instability, organisational routines, physical infrastructure and professional identity than by patient or clinician rejection of the model.

Implications: Telerehabilitation should be treated as a service configuration requiring deliberate design and targeting rather than as an intervention with a fixed effect.

Conclusion: The central unresolved problem is no longer whether physiotherapy telerehabilitation can work, but for whom, in what combination with in-person care, and under what system conditions it can be sustained without displacing the people it was intended to reach.

Artificial Intelligence in Musculoskeletal Physiotherapy: A Critical Narrative Review of Diagnosis, Clinical Decision Support and Personalised Exercise Prescription

2026-09-14T08:17:28+00:00

Musculoskeletal disorders account for a substantial share of global years lived with disability, and physiotherapy services in most health systems operate under demand that exceeds available capacity. Artificial intelligence has been proposed as a means of sharpening diagnostic judgement, structuring clinical reasoning and individualising exercise prescription. These three functions have developed along largely separate research trajectories, and they have rarely been appraised together against the specific epistemic and practical requirements of musculoskeletal physiotherapy. This critical narrative review evaluates the strength, consistency and translational maturity of the evidence across the three domains, drawing on literature retrieved from open scholarly databases and indexes and appraised for methodological adequacy rather than catalogued descriptively. The strongest evidence concerns image-based detection tasks, where deep learning systems achieve accuracy comparable with experienced readers and, when used as an assistive adjunct, improve human sensitivity without lengthening reading time. Evidence weakens considerably as the task moves towards the questions physiotherapists actually ask. Prognostic and triage models are typically developed in single cohorts, are seldom externally validated, and have almost never been tested for their effect on patient outcomes. Generative language models display case-dependent agreement with expert diagnoses under constrained conditions, alongside measurable rates of guideline omission and fabricated citation. Sensing technologies for exercise monitoring have advanced rapidly, yet joint-angle errors from markerless video remain large relative to the differences clinicians attempt to detect, and adaptive dosing algorithms have been evaluated predominantly in simulation or in healthy volunteers rather than in symptomatic populations. Across all three domains, the dominant limitation is not algorithmic performance but the absence of prospective, clinically anchored evaluation. Progress will depend less on further accuracy gains than on external validation, transparent reporting, and trials in which the outcome of interest is a change in patient function rather than a change in model discrimination.

Wearable Sensor Technology in Physiotherapy: From Passive Monitoring to Real-Time Biofeedback. A Critical Narrative Review of Measurement Validity, Therapeutic Mechanism and Clinical Translation

2026-09-14T08:20:37+00:00

Wearable sensors have entered physiotherapy through two distinct routes. The first is passive monitoring, in which body-worn devices quantify movement and activity without attempting to alter them. The second is real-time biofeedback, in which sensor-derived signals are returned to the patient during performance with the explicit intention of changing it. These applications are frequently discussed as a single technological trajectory, yet they rest on different assumptions, require different forms of validation and have accumulated evidence of markedly different quality. This critical narrative review examines the strength, consistency and methodological adequacy of the evidence linking wearable sensing to physiotherapy outcomes, and interrogates the widely repeated but seldom tested premise that better measurement of movement produces better rehabilitation. Literature was identified through open scholarly databases and indexes, supplemented by citation searching, and appraised for design adequacy, measurement transparency, control condition credibility and outcome relevance. Three findings dominate the synthesis. Measurement performance is parameter-dependent rather than device-dependent: spatial gait descriptors achieve agreement adequate for clinical inference, whereas temporal descriptors, joint kinematics and measurements taken on impaired limbs retain error margins that overlap the changes clinicians seek to detect. Passive monitoring reveals a reproducible dissociation between what patients can do under observation and what they do in daily life, and interventions that improve one do not reliably improve the other. Real-time biofeedback produces effects that track the specificity of the biomechanical target rather than the sophistication of the sensing hardware; feedback aimed at a mechanistically justified, individually determined target has altered loading, symptoms and tissue-level outcomes, whereas feedback appended to an already effective behavioural intervention has repeatedly added nothing. Confidence in generalisation is limited by small samples, brief follow-up, weak control conditions and concentration of evidence in few research groups. Priorities include target-specific efficacy trials, retention-focused designs, error thresholds anchored to clinical decisions, and implementation research addressing workforce readiness and equitable access.

Virtual Reality-assisted Therapeutic Exercise for Chronic Musculoskeletal Pain: A Critical Review of Mechanisms, Modalities and Clinical Translation

2026-09-14T08:25:32+00:00

Chronic musculoskeletal pain is the largest single contributor to years lived with disability worldwide, and structured therapeutic exercise remains the intervention most consistently endorsed in clinical guidance despite average treatment effects that are modest and frequently short-lived. Virtual reality has been proposed as a means of changing the experience of exercising while in pain, and the number of randomised trials in this area has grown quickly. The resulting literature is difficult to interpret: pooled effect estimates range from negligible to implausibly large, and the reasons for that divergence have received little systematic attention. This critical narrative review integrates mechanistic, clinical and implementation evidence on virtual reality-assisted therapeutic exercise in adults with chronic musculoskeletal pain, with the specific aim of explaining why the field appears at once encouraging and internally contradictory. Evidence was retrieved from openly accessible bibliographic sources and appraised for design adequacy, comparator quality, outcome measurement and reporting transparency. Interventions grouped under a single label are shown to differ along at least six independent dimensions, including display immersion, movement demand, therapeutic content and supervision, and this heterogeneity propagates directly into synthesis. Five candidate mechanisms are distinguished and evaluated separately: attentional modulation, multisensory and body-representation manipulation, reduction of movement-related fear, exercise dose and exercise-induced hypoalgesia, and expectancy. Effect estimates scale inversely with methodological rigour. Small trials with inert comparators report standardised mean differences that exceed any plausible analgesic effect, whereas the largest sham-controlled trial reports a between-group difference of well under one point on an eleven-point scale, and two independent pragmatic cluster-randomised trials report no benefit. The most defensible conclusion is that virtual reality currently alters the experience of exercising, particularly enjoyment, tolerance and engagement, more reliably than it alters pain. Priority research needs are mechanistically informative designs with formal mediation analysis, comparator standardisation, adequately powered pragmatic trials with meaningful follow-up, and consistent reporting of intervention content.